A clinical trial, published in JAMA Neurology, has found that Nilotinib, a drug used for the treatment of leukemia, has been found safe and effective in people with Parkinson’s disease. Nilotinib may increase dopamine metabolism and potentially treat motor and non-motor symptoms of Parkinson’s disease. However, it is still under clinical trial, because of the few safety concerns caused due to higher dose of nilotinib.
Source:- http://bit.ly/2EG5VVy
That’s a bit of good news for those with Parkinsons or their carers.
My grandmother and her sisters all had Parkinsons, so I take an interest in the disease, with my fingers firmly crossed!